Antibiotic utilization in endoscopic dacryocystorhinostomy: a multi-institutional study and review of the literature

Orbit. 2024 Apr;43(2):183-189. doi: 10.1080/01676830.2023.2227705. Epub 2023 Jul 3.

Abstract

Purpose: Utilization of antibiotics for endoscopic dacryocystorhinostomy (endo-DCR) is largely dependent on individual surgeon preference. This study aimed to investigate prescribing practices of pre-, peri-, and postoperative antibiotics and effects on postoperative infection rates in patients who underwent endo-DCR.

Methods: A retrospective chart review of institutional data at two academic centers of endo-DCR cases from 2015-2020 was performed. Postoperative infection rates for patients who received pre-, peri-, and postoperative antibiotics, individually or in combination, and those who did not, were compared via odds ratio and ANOVA linear regression.

Results: 331 endo-DCR cases were included; 22 cases (6.6%) had a postoperative infection. There was no significant difference in the infection rates between patients without an active preoperative dacryocystitis who received different permutations of peri- and postoperative antibiotics. Patients who received preoperative antibiotics within two weeks of surgery for preexisting acute dacryocystitis, but did not receive peri- or postoperative antibiotics, had a higher rate of postoperative infections (p = 008).

Conclusions: Our data suggest antibiotics may be beneficial only when patients have a recent or active dacryocystitis prior to surgery. Otherwise, our data do not support the routine use of antibiotic prophylaxis in endo-DCR.

Keywords: Nasolacrimal duct obstruction; antibiotic utilization; dacryocystitis; endoscopic dacryocystorhinostomy; prophylactic antibiotics.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Dacryocystitis* / drug therapy
  • Dacryocystitis* / surgery
  • Dacryocystorhinostomy*
  • Endoscopy
  • Humans
  • Multicenter Studies as Topic
  • Nasolacrimal Duct* / surgery
  • Postoperative Complications / surgery
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents